ATC
AZN icon

Adirondack Trust Company’s AstraZeneca AZN Stock Holding History

Adirondack Trust Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
543
-5
-0.9% -$940 0.03% 201
2026
Q1 		$108K Sell
548
-3
-0.5% -$578 0.04% 189
2025
Q4 		$101K Buy
551
+43
+8% +$7.54K 0.03% 193
2025
Q3 		$77.9K Buy
508
+119
+31% +$18K 0.03% 210
2025
Q2 		$54.4K Hold
389
– – 0.02% 239
2025
Q1 		$57.2K Hold
389
– – 0.02% 225
2024
Q4 		$51K Hold
389
– – 0.02% 240
2024
Q3 		$60.6K Hold
389
– – 0.02% 231
2024
Q2 		$60.7K Sell
389
-116
-23% -$17.5K 0.02% 223
2024
Q1 		$68.4K Buy
505
+5
+1% +$662 0.03% 213
2023
Q4 		$64.1K Hold
500
– – 0.03% 215
2023
Q3 		$67.6K Hold
500
– – 0.03% 196
2023
Q2 		$71.6K Buy
500
+290
+138% +$42.7K 0.03% 187
2023
Q1 		$29.1K Hold
210
– – 0.01% 239
2022
Q4 		$28.5K Hold
210
– – 0.01% 239
2022
Q3 		$23K Hold
210
– – 0.01% 246
2022
Q2 		$28K Hold
210
– – 0.02% 223
2022
Q1 		$28K Hold
210
– – 0.01% 225
2021
Q4 		$24K Hold
210
– – 0.01% 231
2021
Q3 		$26K Hold
210
– – 0.01% 231
2021
Q2 		$25K Sell
210
-28
-12% -$3.07K 0.01% 232
2021
Q1 		$24K Hold
238
– – 0.01% 229
2020
Q4 		$24K Hold
238
– – 0.01% 218
2020
Q3 		$26K Hold
238
– – 0.02% 188
2020
Q2 		$26K Buy
238
+28
+13% +$2.89K 0.02% 193
2020
Q1 		$19K Hold
210
– – 0.02% 194
2019
Q4 		$20K Buy
210
+12
+6% +$1.13K 0.01% 212
2019
Q3 		$18K Buy
198
+25
+14% +$2.17K 0.01% 218
2019
Q2 		$14K Hold
173
– – 0.01% 240
2019
Q1 		$13K Buy
173
+13
+8% +$1.02K 0.01% 228
2018
Q4 		$12K Hold
160
– – 0.01% 227
2018
Q3 		$13K Hold
160
– – 0.01% 235
2018
Q2 		$11K Hold
160
– – 0.01% 231
2018
Q1 		$11K Sell
160
-33
-17% -$2.29K 0.01% 238
2017
Q4 		$13K Sell
193
-32
-14% -$2.16K 0.01% 222
2017
Q3 		$15K Hold
225
– – 0.01% 214
2017
Q2 		$15K Buy
225
+80
+55% +$5.22K 0.01% 215
2017
Q1 		$9K Buy
145
+35
+32% +$2.04K 0.01% 251
2016
Q4 		$6K Buy
110
+77
+233% +$4.37K ﹤0.01% 262
2016
Q3 		$2K Buy
+33
New +$2.16K ﹤0.01% 311

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

Adirondack Trust Company's AZN Position: Q2 2026 in Review

Adirondack Trust Company reduced its AstraZeneca (AZN) stake by 0.91% in Q2 2026, selling an estimated $940 and leaving 543 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #201.

Adirondack Trust Company first reported a position in AZN in Q3 2016 and has held it in 40 quarters since. The position peaked at $108K in Q1 2026. 373 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Adirondack Trust Company held 543 shares of AstraZeneca worth $103K as of Q2 2026.
  • Adirondack Trust Company sold 5 AstraZeneca shares in Q2 2026, an estimated $940.
  • AstraZeneca made up 0.03% of Adirondack Trust Company's portfolio in Q2 2026, its #201 holding.
  • Adirondack Trust Company first reported a position in AstraZeneca in Q3 2016 and has held it in 40 quarters since.
  • Adirondack Trust Company's AstraZeneca position peaked at $108K in Q1 2026.
  • 373 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.